Format

Send to

Choose Destination
Nat Rev Immunol. 2011 May;11(5):343-54. doi: 10.1038/nri2960. Epub 2011 Apr 8.

Immunological biomarkers of tuberculosis.

Author information

1
Immunology Research Group, NRF/DST Centre of Excellence for TB Biomedical Research, Division of Molecular Biology and Human Genetics, Faculty of Health Sciences, Stellenbosch University, South Africa. gwalzl@sun.ac.za

Abstract

Currently there are no sufficiently validated biomarkers to aid the evaluation of new tuberculosis vaccine candidates, the improvement of tuberculosis diagnostics or the development of more effective and shorter treatment regimens. To date, the detection of Mycobacterium tuberculosis or its products has not been able to adequately address these needs. Understanding the interplay between the host immune system and M. tuberculosis may provide a platform for the identification of suitable biomarkers, through both unbiased and targeted hypothesis-driven approaches. Here, we review immunological markers, their relation to M. tuberculosis infection stages and their potential use in the fight against tuberculosis.

PMID:
21475309
DOI:
10.1038/nri2960
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center